GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anuh Pharma Ltd (BOM:506260) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Anuh Pharma (BOM:506260) Future 3-5Y EPS without NRI Growth Rate : N/A (As of May. 27, 2025)


View and export this data going back to 1993. Start your Free Trial

What is Anuh Pharma Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Anuh Pharma's Future 3-5Y EPS without NRI Growth Rate is N/A.

Competitive Comparison of Anuh Pharma's Future 3-5Y EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Anuh Pharma's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Anuh Pharma's Future 3-5Y EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Anuh Pharma's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Anuh Pharma's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Anuh Pharma  (BOM:506260) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.

Anuh Pharma Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Anuh Pharma's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Anuh Pharma Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Anuh Pharma Ltd (BOM:506260) » Definitions » Future 3-5Y EPS without NRI Growth Rate
Comparable Companies
BOM:539997 BOM:531633 BOM:524212 BOM:506414 BOM:541096 BOM:540737 BOM:530199 BOM:506197 BOM:524500 BOM:507789 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
ANUHPHR:India
Address
Dr. Annie Besant Road, North Wing, 3-A, Shiv Sagar Estate, Worli, Mumbai, MH, IND, 400 018
Website
https://www.anuhpharma.com
Anuh Pharma Ltd is engaged in the business of manufacturing and selling of Bulk drugs and chemicals. Geographically, it derives a majority of revenue from India. Its product categories include macrolides, anti-TB, anti-malarial, anti-bacterial, anti-hypertension, expectorant, quinolones, and others. The company generates revenue from the sale of Branded Prescription drugs, Over-the-Counter (OTC) drugs and Generic Prescription drugs.

Anuh Pharma Headlines

No Headlines